Efficacy of Stiripentol Beyond Dravet Syndrome: A Retrospective Medical Record Review of Patients with Drug-Resistant Epilepsies

Abstract Introduction Stiripentol is approved as an add-on therapy with clobazam and/or valproate for seizures associated with Dravet syndrome (DS). Evidence of stiripentol efficacy in other drug-resistant epilepsies is limited. Methods This was a single-centre, retrospective, observational study of...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Neurology and Therapy
المؤلفون الرئيسيون: Víctor Soto-Insuga, Elena González-Alguacil, María Ballarà-Petitbò, Nuria Lamagrande-Casanova, Anna Duat-Rodríguez, Cristina Benítez-Provedo, Elena Cardenal-Muñoz, Juan José García-Peñas
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Adis, Springer Healthcare 2025-05-01
الموضوعات:
Children
Dravet syndrome
Drug-resistant epilepsy
Status epilepticus
Stiripentol
الوصول للمادة أونلاين:https://doi.org/10.1007/s40120-025-00755-5

الانترنت

https://doi.org/10.1007/s40120-025-00755-5

مواد مشابهة